J 2016

The Chemical Composition of Achillea wilhelmsii C. Koch and Its Desirable Effects on Hyperglycemia, Inflammatory Mediators and Hypercholesterolemia as Risk Factors for Cardiometabolic Disease

KHAZNEH, E.; P. HRIBOVA; J. HOSEK; Pavel SUCHÝ; Peter KOLLÁR et al.

Základní údaje

Originální název

The Chemical Composition of Achillea wilhelmsii C. Koch and Its Desirable Effects on Hyperglycemia, Inflammatory Mediators and Hypercholesterolemia as Risk Factors for Cardiometabolic Disease

Autoři

KHAZNEH, E.; P. HRIBOVA; J. HOSEK; Pavel SUCHÝ; Peter KOLLÁR; G. PRAZANOVA; Jan MUSELÍK; Z. HANAKOVA; Jiří VÁCLAVÍK; M. MILEK; J. LEGATH a Karel ŠMEJKAL

Vydání

Molecules, BASEL, Mayer und Muller, 2016, 1420-3049

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30104 Pharmacology and pharmacy

Utajení

není předmětem státního či obchodního tajemství

Impakt faktor

Impact factor: 2.861

Označené pro přenos do RIV

Ne

Organizační jednotka

Farmaceutická fakulta

EID Scopus

Klíčová slova anglicky

Achillea wilhelmsii; anti-hypercholesterolemic; cardiometabolic disease; docking; flavonoids; 3-hydroxy-3-methylglutaryl-CoA reductase; hypoglycemic; inflammation
Změněno: 24. 2. 2021 14:15, PharmDr. Jitka Michlíčková

Anotace

V originále

This study was done to identify the content compounds of Achillea wilhelmsii (A. wilhelmsii) and to evaluate its hypoglycemic and anti-hypercholesterolemic activity and effect on inflammatory mediators. The extracts and fractions of A. wilhelmsii were thoroughly analyzed using high performance liquid chromatography (HPLC), and the total content of phenols and flavonoids was determined. The hypoglycemic activity was evaluated in vivo using alloxan-induced diabetic mice. The effect upon inflammatory mediators was evaluated in vitro using the human monocytic leukemia cell line (THP-1). The anti-hypercholesterolemic activity was evaluated in vitro using the 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase assay kit. The water extract (WE)-treated group showed the highest reduction in the fasting blood glucose levels (FBGL). The chloroform fraction (CF) and ethyl acetate fraction (EAF) both showed a significant ability to reduce the secretion of tumor necrosis factor alpha (TNF-alpha). The EAF, however, also attenuated the levels of matrix metalloproteinase-2 (MMP-2) and matrix metalloproteinase-9 (MMP-9). The CF showed the most significant 3-hydroxy-3-methylglutaryl-CoA reductase (HMGR) inhibition activity. The five main compounds in the CF were isolated and identified. Out of the five compounds in the CF, 1 beta,10 beta-epoxydesacetoxymatricarin (CP1) and leucodin (CP2) showed the highest anti-hypercholesterolemic potential. A molecular docking study provided corresponding results.